Signage for Novartis AG at a building in the company's headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023.
Bloomberg | Bloomberg | Getty Images
Shares of Swiss drugmaker Novartis climbed 4.8% in early deals on Tuesday, after the company raised its full-year guidance following better-than-expected first-quarter results.
The company said 2024 net sales are now anticipated to pick up by a high-single to low double-digit percentage, up from a previous outlook of mid-single-digit growth.
The drugmaker has also revised its expectations for core operating income, now set to expand by a low double-digit to mid-teens percentage, up from the high single-digit growth forecast prior.
This breaking news story is being updated.
English (US) · 
Turkish (TR) · 